COMBINED SODIUM FLUORIDE AND CALCIUM CITRATE THERAPY IN OSTEOPOROSIS

氟化钠和柠檬酸钙联合治疗骨质疏松症

• 批准号: 5220888
• 负责人: KHASHAYAR SAKHAEE
• 金额: --
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/5220888
• 关键词: calcium; citrates; clinical research; clinical trials; combination chemotherapy; fluorine; human subject; human therapy evaluation; hypoglycemia; metabolism disorder chemotherapy; nutrition related tag; osteoporosis; skeletal disorder chemotherapy; slow release drug; sodium

The purpose is to determine whether or not the amount of bone in persons suffering from osteoporosis can be increased using a combination of slow release sodium fluoride and calcium citrate. Since this is a non-randomized study, only previously entered patients continue to be studied. New patients are entered into the randomized trials underway via sister projects.

目的是确定人的骨量是否 使用缓慢的组合可以增加患有骨质疏松症的风险 释放氟化钠和柠檬酸钙。 由于这是一个 非随机研究，只有先前进入的患者继续 研究过。 新患者进入正在进行的随机试验 通过姐妹项目。